Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Clinical trial NCT01516736 · COMPLETED

Trial details

NCT number: NCT01516736
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Neutropenia Breast Cancer

Start date: 2012-03-01
Primary completion: 2013-08-01
Enrollment: 308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.